BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 32299435)

  • 1. Identification of hub genes in papillary thyroid carcinoma: robust rank aggregation and weighted gene co-expression network analysis.
    Liu Y; Chen TY; Yang ZY; Fang W; Wu Q; Zhang C
    J Transl Med; 2020 Apr; 18(1):170. PubMed ID: 32299435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying gene modules of thyroid cancer associated with pathological stage by weighted gene co-expression network analysis.
    Tang X; Huang X; Wang D; Yan R; Lu F; Cheng C; Li Y; Xu J
    Gene; 2019 Jul; 704():142-148. PubMed ID: 30965127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of gene co-expression modules and hub genes associated with lymph node metastasis of papillary thyroid cancer.
    Zhai T; Muhanhali D; Jia X; Wu Z; Cai Z; Ling Y
    Endocrine; 2019 Dec; 66(3):573-584. PubMed ID: 31332712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Transcriptional Pattern Related to Immune Cell Infiltration With Gene Co-Expression Network in Papillary Thyroid Cancer.
    Li M; Zhang J; Zhang Z; Qian Y; Qu W; Jiang Z; Zhao B
    Front Endocrinol (Lausanne); 2022; 13():721569. PubMed ID: 35185791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysis.
    Xue G; Lin X; Wu JF; Pei D; Wang DM; Zhang J; Zhang WJ
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32766727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer.
    Zhao H; Li H
    Gene; 2018 Jun; 661():160-168. PubMed ID: 29625265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
    Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
    World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of key genes associated with papillary thyroid microcarcinoma characteristics by integrating transcriptome sequencing and weighted gene co-expression network analysis.
    Yang F; Lian M; Ma H; Feng L; Shen X; Chen J; Fang J
    Gene; 2022 Feb; 811():146086. PubMed ID: 34856364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key candidate genes associated with BRAF
    Yu X; Zhong P; Han Y; Huang Q; Wang J; Jia C; Lv Z
    J Cell Physiol; 2019 Dec; 234(12):23369-23378. PubMed ID: 31161615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics analysis identified shared differentially expressed genes as potential biomarkers for Hashimoto's thyroiditis-related papillary thyroid cancer.
    Liu C; Pan Y; Li Q; Zhang Y
    Int J Med Sci; 2021; 18(15):3478-3487. PubMed ID: 34522174
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel lncRNA-miRNA-mRNA network analysis identified the hub lncRNA RP11-159F24.1 in the pathogenesis of papillary thyroid cancer.
    Jiang W; Zhan H; Jiao Y; Li S; Gao W
    Cancer Med; 2018 Dec; 7(12):6290-6298. PubMed ID: 30474931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative Analysis of Potential Biomarkers Involved in the Progression of Papillary Thyroid Cancer.
    Bansal R; Saxena U
    Appl Biochem Biotechnol; 2023 May; 195(5):2917-2932. PubMed ID: 36445679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and analysis of genes associated with papillary thyroid carcinoma by bioinformatics methods.
    Zhang S; Wang Q; Han Q; Han H; Lu P
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30872410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of potential target genes in papillary thyroid cancer.
    Zhang K; Liu J; Li C; Peng X; Li H; Li Z
    Eur J Pharmacol; 2019 Jan; 843():217-225. PubMed ID: 30472204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of
    Zhang Y; Xie X; Zhou H; Li B; Ding L; Cai Z; Song H; Zhao S; Xu H
    Front Endocrinol (Lausanne); 2023; 14():1131078. PubMed ID: 37455914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential biomarkers and drugs for papillary thyroid cancer based on gene expression profile analysis.
    Qu T; Li YP; Li XH; Chen Y
    Mol Med Rep; 2016 Dec; 14(6):5041-5048. PubMed ID: 27779685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas.
    Beltrami CM; Dos Reis MB; Barros-Filho MC; Marchi FA; Kuasne H; Pinto CAL; Ambatipudi S; Herceg Z; Kowalski LP; Rogatto SR
    Clin Epigenetics; 2017; 9():45. PubMed ID: 28469731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of differentiated functional modules in papillary thyroid carcinoma by analyzing differential networks.
    Yang C; Wang Y
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S969-S974. PubMed ID: 30539831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL12 methylation-mediated epigenetic regulation of gene expression in papillary thyroid carcinoma.
    Zhang S; Wang Y; Chen M; Sun L; Han J; Elena VK; Qiao H
    Sci Rep; 2017 Mar; 7():44033. PubMed ID: 28272462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.